Decreased insulin receptor tyrosine kinase activity and plasma cell membrane glycoprotein-1 overexpression in skeletal muscle from obese women with gestational diabetes mellitus (GDM): Evidence for increased serine/threonine phosphorylation in pregnancy and GDM

Diabetes

Volumn 49, Issue 4, 2000, Pages 603-610

  Shao, Jianhua ^a   Catalano, Patrick M ^a   Yamashita, Hiroshi ^a   Ruyter, Irene ^b   Smith, Steven ^b   Youngren, Jack ^c   Friedman, Jacob E ^a,d  

^a METROHEALTH MEDICAL CENTER   (United States)

^b PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^c UNIVERSITY OF SAN FRANCISCO   (United States)

^d CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; GLYCOPROTEIN; INSULIN RECEPTOR KINASE; PROTEIN SERINE THREONINE KINASE;

ADULT; ARTICLE; AUTOPHOSPHORYLATION; CLINICAL ARTICLE; CONTROLLED STUDY; DEPHOSPHORYLATION; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; GENE OVEREXPRESSION; HUMAN; INSULIN RESISTANCE; OBESITY; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECEPTOR INTRINSIC ACTIVITY; RISK; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

EID: 0034127077     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.49.4.603     Document Type: Article

References (57)

1. Catalano PM, Tyzbir ED, Wolfe RR, Roman NM, Amini SB, Sims EA: Longitudinal changes in insulin release and insulin resistance in non-obese pregnant women. Am J Obstet Gynecol 165:1667-1672, 1991
2. Costrini NV, Kalkhoff RK: Relative effects of pregnancy, estradiol and progesterone on plasma insulin and pancreatic islet insulin secretion. J Clin Invest 50:922-929, 1971
3. Barden TP, Knowles HC: Diagnosis of diabetes in pregnancy. Clin Obstet Gynecol 24:3-19, 1981
4. Buchanan TA, Metzger BE, Freinkel N, Bergman RN: Insulin sensitivity and beta cell responsiveness to glucose during late pregnancy in lean and moderately obese women with normal glucose tolerance or mild gestational diabetes. Am J Obstet Gynecol 162:1008-1014, 1990
5. Kul C: Insulin secretion and insulin resistance in pregnancy and GDM. Diabetes (Suppl. 1) 2:18-24, 1991
6. Kautzky-Willer A, Prager R, Waldhausl W, Pacini G, Thomaseth K, Wagner OF, Ulm M, Streli C, Ludvik B: Pronounced insulin resistance and inadequate β-cell secretion characterize lean gestational diabetes during and after pregnancy. Diabetes Care 20:1717-1723, 1997
7. Kjos SL, Peter RK, Xiang A, Henry OA, Montoro M, Buchanan TA: Predicting future diabetes in Latino women with gestational diabetes: utility of early postpartum glucose tolerance testing. Diabetes 44:586-591, 1995
8. Hagbard L, Svanborg A: Prognosis of diabetes mellitus with onset during pregnancy: a clinical study of 71 cases. Diabetes 9:296-302, 1960
9. Pettitt DJ, Baird HR, Aleck KA, Bennett PH, Knowler WC: Excessive obesity in offspring of Pima Indian women with diabetes during pregnancy. N Engl J Med 308:242-245, 1983
10. Friedman JE, Ishizuka T, Huston L, Highman T, Shao JH, Catalano P: Impaired glucose transport and insulin receptor tyrosine phosphorylation in obese women with gestational diabetes mellitus. Diabetes 48:1807-1814, 1999
11. Moore P, Kolterman O, Weynat J, Olefsky JM: Insulin binding in human pregnancy: comparisons to the postpartum, luteal and follicular states. J Clin Endocrinol Melab 52:937-941, 1981
12. Puavilai G, Dorbny EC, Domont LA: Insulin receptors and insulin resistance in human pregnancy: evidence for a postreceptor defect in insulin action. J Clin Endocrinol Metab 54:247-253, 1982
13. Camps M, Guma A, Testar X, Palacin M, Zorzano A: Insulin resistance of skeletal muscle during pregnancy is not a consequence of intrinsic modifications of insulin receptor binding or kinase activities. Endocrinology 127: 2561-2570, 1990
14. Damm P, Handberg A, Kuhl C, Beck-Nielsen H, Molsted-Pedersen L: Insulin receptor binding and tyrosine kinase activity in skeletal muscle from normal pregnant women and women with gestational diabetes. Obstet Gynecol 82:251-259, 1993
15. White MF, Shoelson SE, Keutmann H, Kahn CR: A cascade of tyrosine autophosphorylation in the B-subunit activates the insulin receptor. J Biol Chem 263:2969-2975, 1988
16. Wilden PA, Siddel K, Haring H, Backer JM, White MF, Kahn CR: The role of insulin receptor kinase domain autophosphorylation in receptor-mediated activities. J Biol Chem 267:13719-13726, 1992
17. White MF, Kahn CR: The insulin signaling system. J Biol Chem 269:1-4, 1994
18. Shraccia P, Goodman PA, Muddux BA, Wong KY, Chen YD, Reaven GM, Goldfine ID: Production of an inhibitor of insulin receptor tyrosine kinase in fibroblasts from a patient with insulin resistance and NIDDM. Diabetes 40:295-299, 1991
19. Maddux BA, Sbraccia P, Reaven GM, Moller DE, Goldfine ID: Inhibitors of insulin receptor tyrosine kinase in fibroblasts from diverse patients with impaired insulin action: evidence for a novel mechanism of postreceptor insulin resistance. J Clin Endocrinol Metab 77:73-79, 1993
20. Maddux BA, Sbraccia P, Kumakura S, Sasson S, Youngren J, Fisher A, Spencer S, Grupe A, Henzel W, Stewart TA, Reaven GM, Goldfine ID: Membrane glucoprotein PC-1 and insulin resistance in non-insulin-dependent diabetes mellitus. Nature 373:448-451, 1995
21. Goldfine ID, Maddux BA, Youngren JF, Frittitta L, Trischitta V, Dohn GL: Membrane glycoprotein PC-1 and insulin resistance. J Cell Biochem 182:177-184, 1998
22. Youngren JF, Maddux BA, Sasson S, Sbraccia P, Tapscott EB, Swanson MS, Dohm GL, Goldfine ID: Skeletal muscle content of membrane glycoprotein PC-1 in obesity. Diabetes 45:1324-1328, 1996
23. Frittitta L, Sampinato D, Solini A, Nosadini R, Goldfine ID, Vigneri R, Trischitta V: Elevated PC-1 content in cultured skin fibroblasts correlates with decreased in vivo and in vitro insulin action in nondiabetic subjects: evidence that PC-1 may be an intrinsic factor in impaired insulin receptor signaling. Diabetes 47:1095-1100, 1998
24. Kumakura S, Maddux BA, Sung CK: Overexpression of membrane glycoprotein PC-1 can influence insulin action at a post-receptor site. J Cell Biochem 68:366-377, 1998
25. White MF, Takayama S, Kahn CR: Differences in the sites of phosphorylation of the insulin receptor in vivo and in vitro. J Biol Chem 260:9470-9478, 1985
26. Zick Y: The insulin receptor: structure and function. Crit Rev Biochem Mol Biol 24:217-269, 1989
27. Takatama S, White MF, Kahn CR: Phorbol ester-induced serine phosphorylation of the insulin receptor decreases its tyrosine kinase activity. J Biol Chem 263:3440-3447, 1988
28. Forsyeth JR, Caro JF, Sinha MK, Maddux BA, Goldfine ID: Monoclonal antibodies to the human insulin receptor that activate glucose transport but not insulin receptor kinase activity. Proc Natl Acad Sci USA 84:3448-3451, 1987
29. National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and other categories of glucose tolerance. Diabetes 28:1039-1057, 1979
30. Catalano PM, Wong WW, Drago NM, Amini SB: Estimating body composition in late gestation: a new hydration constant for body density and total body water. Am J Physiol 268:E153-E158, 1995
31. Drago NM, Wong W, Amini SB, Catalano PM: Anthropometric estimation of maternal body composition in late gestation (Abstract). J Soc Gynecol Invest 2:167, 1995
32. Youngren JF, Goldfine ID, Pratley RE: Decreased muscle insulin receptor kinase correlates with insulin resistance in normoglycemic Pima Indians. Am J Physiol 237:E1-E8, 1997
33. Berkowitz GS, Roman SH, Lapinski RH, Alvarez M: Maternal characteristics, neonatal outcome, and the time of diagnosis of gestational diabetes. Am J Obstet Gynecol 167:976-982, 1992
34. Mouzon SH, Peraldi P, Alengrin F, Obberghen EV: Alteration of phosphotyrosine phosphatase activity in tissues from diabetic and pregnant rats. Endocrinology 132:67-74, 1992
35. Martinez C, Ruiz P, Andres A, Satrustegui J, Carrascosa JM: Tyrosine kinase activity of liver insulin receptor is inhibited in rats at term gestation. Biochem J 263:267-272, 1989
36. Nolan JJ, Freidenberg G, Henry R, Reichart D, Olefsky JM: Role of human skeletal muscle insulin receptor kinase in the in vivo insulin resistance of non-insulin-dependent diabetes mellitus and obesity. J Clin Endocrinol Metab 78:471-477, 1994
37. Caro JF, Sinha MK, Raju SM, Ittoop O, Pories WJ, Flickinger EG, Meelheim D, Dohm GL: Insulin receptor kinase in human skeletal muscle from obese subjects with and without noninsulin dependent diabetes. J Clin Invest 79:1330-1337, 1987
38. Bollag GE, Roth RA, Beaudoin J, Mochly-Rosen D, Koshland DEJ: Protein kinase C directly phosphorylates the insulin receptor in vitro and reduces its protein-tyrosine kinase activity. Proc Natl Acad Sci U S A 83:5822-5824, 1986
39. Pillay TS, Xiao S, Olefsky JM: Glucose-induced phosphorylation of the insulin receptor. J Clin Invest 97:613-620, 1996
40. Kellerer M, Coghlan M, Capp E, Muhlhofer A, Kroder G, Mosthaf L, Galante P, Siddle K, Haring H-U: Mechanism of insulin receptor kinase inhibition in non-insulin-dependent diabetes mellitus patients: phosphorylation of serine 1327 or threonine 1348 is unaltered. J Clin Invest 96:6-11, 1995
41. Dunaif A, Xia J, Book C-B, Schenker E, Tang Z: Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle: a potential mechanism for insulin resistance in the polycystic ovary syndrome. J Clin Invest 96:801-810, 1995
42. Raj SG, Thompson IE, Berger MJ, Taymor ML: Clinical aspects of the polycystic ovary syndrome. Obstet Gynecol 49:552-556, 1977
43. Holte J: Polycystic ovary syndrome and insulin resistance: thrifty genes struggling with over-feeding and sedentary life style? J Clin Endocrinol Invest 21:589-601, 1998
44. Feener EP, Shiba T, Hu KQ, Wilden PA, White MF, King GL: Characterization of phorbol ester-stimulated serine phosphorylation of the human insulin receptor. Biochem J 303:43-50, 1994
45. Avignon A, Yamada K, Zhou X, Spencer B, Cardona O, Saba-Siddique S, Galloway L, Standaert ML, Farese RV: Chronic activation of protein kinase C in soleus muscles and other tissues of insulin-resistant type II diabetic Goko-Kakazaki (GK), obese/aged, and obese/Zucker rats: a mechanism for inhibiting glycogen synthesis. Diabetes 45:1396-1404, 1996
46. Schmitz-Peiffer C, Browne CL, Oakes ND, Watkinson A, Chisholm DJ, Kraegen EW, Biden TJ: Alteration in the expression and cellular localization of protein kinase C isozymes epsilon and theta are associated with insulin resistance in skeletal muscle of the high-fat-fed rat. Diabetes 46:169-178, 1997
47. Paz K, Hemi R, LeRoith D, Karasik A, Elhanany E, Kanety H, Zick Y: A molecular basis for insulin resistance. J Biol Chem 272:29911-29918, 1997
48. Hotamisligu GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM: IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha-and obesity-induced insulin resistance. Science 271:665-668, 1996
49. Catalano P, Highman T, Huston L, Friedman JE: Relationship between reproductive hormones/TNF-α and longitudinal changes in insulin sensitivity during gestation. Diabetes 45 (Suppl. 2):175, 1996
50. Oda Y, Kuo M-D, Huang SS, Huang JS: The plasma cell membrane glycoprotein, PC-1, is a threonine specific protein kinase stimulated by acidic fibroblast growth factor. J Biol Chem 266:16791-16795, 1991
51. Goding JW, Terkeltaub R, Maurice M, Deterre P, Sali A, Belli S: Ecto-phosphodiesterase/pyrophosphatase of lymphocytes and non-lymphoid cells: structure and function of the PC-1 family. Immunol Rev 161:11-26, 1998
52. Maddux BA, Goldfine ID: 2000 PC-1 inhibition of insulin receptor function occurs via direct interaction with the receptor alpha subunit. Diabetes 49:13-19, 2000
53. Belfiore A, Costantino A, Frasca F, Pandini G, Mineo R, Vigneri P, Maddux B, Goldfine ID, Vigneri R: Overexpression of membrane glycoprotein PC-1 in MDA-MB231 breast cancer cells is associated with inhibition of insulin receptor tyrosine kinase activity. Mol Endocrinol 10:1318-1326, 1996
54. Grupe A, Alleman J, Goldfine ID, Sadick M, Stewart TA: Inhibition of insulin receptor phosphorylation by PC-1 is not mediated by the hydrolysis of adenosine triphosphate or the generation of adenosine. J Biol Chem 270:22085-22088, 1995
55. Frittitta L, Youngren JF, Vigneri R, Maddux V, Trishitta V, Goldfine ID: PC-1 content in skeletal muscle of non-obese, non-diabetic subjects, relationship to insulin receptor tyrosine kinase and whole body insulin sensitivity. Diabetologia 39:1190-1195, 1996
56. Sakoda H, Ogihara T, Anai M, Funak M, Inukai K, Katagiri H, Fukushima Y, Onishi Y, Ono H, Yazaki Y, Kikuchi M, Oka Y, Asano T: No correlation of plasma cell 1 overexpression with insulin resistance in diabetic rats and 3T3-L1 adipocytes. Diabetes 48:1365-1371, 1999
57. Pizzuti A, Frittitta L, Argiolas A, Baratta A, Goldfine ID, Bozzali M, Ercolino T, Scarlato G, Iacoviello L, Vigneri R, Tassi V, Trischitta V: A polymorphism (K121Q) of the human glycoprotein PC-1 gene coding region is strongly associated with insulin resistance. Diabetes 48:1881-1884, 1999